Strate­gic Pri­or­i­ties in Can­cer Ther­a­py: Nav­i­gat­ing the 2026 Can­cer Mis­sion Calls

TBC

TBC

TBC

AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection

Indus­try Con­tact Point

We pro­vide com­pre­hen­sive sup­port for researchers and entre­pre­neurs in the med­ical tech­nol­o­gy and health­care sec­tors in secur­ing fund­ing from the Hori­zon Europe pro­gram. The goal of the Indus­try Con­tact Point for Med­ical Tech­nolo­gies and Health (ICP MTH) is to fos­ter the devel­op­ment of inno­v­a­tive research and the imple­men­ta­tion of break­through tech­no­log­i­cal solu­tions by facil­i­tat­ing access to Euro­pean grant instruments. .

We pro­vide com­pre­hen­sive sup­port for researchers and entre­pre­neurs in the med­ical tech­nol­o­gy and health­care sec­tors in secur­ing fund­ing from the Hori­zon Europe pro­gram. The goal of the Indus­try Con­tact Point for Med­ical Tech­nolo­gies and Health (ICP MTH) is to fos­ter the devel­op­ment of inno­v­a­tive research and the imple­men­ta­tion of break­through tech­no­log­i­cal solu­tions by facil­i­tat­ing access to Euro­pean grant instruments. .

The scope of our activ­i­ties includes:

  • assist­ing in iden­ti­fy­ing suit­able inter­na­tion­al part­ners for project collaboration,
  • rep­re­sent­ing Pol­ish insti­tu­tions at match­mak­ing and bro­ker­age events,
  • orga­niz­ing the­mat­ic train­ings and workshops,
  • pro­vid­ing indi­vid­ual con­sul­ta­tions dur­ing the prepa­ra­tion of project proposals.

How Can We Help?

The Nation­al Con­tact Point for Med­ical Tech­nolo­gies and Health focus­es on key research and devel­op­ment areas such as coör­di­nat­ed health­care and telemed­i­cine, bioin­for­mat­ics and dig­i­tal tools sup­port­ing ther­a­peu­tic process­es, mod­ern and per­son­al­ized diag­nos­tics, bio­med­ical engi­neer­ing and pro­tein ther­a­pies, as well as the devel­op­ment of inno­v­a­tive mate­ri­als for med­ical appli­ca­tions and advanced tech­nolo­gies for the man­u­fac­tur­ing of med­i­c­i­nal prod­ucts, includ­ing advanced ther­a­py med­i­c­i­nal prod­ucts (ATMPs).

The Hori­zon Europe Pro­gram is the largest research and inno­va­tion fund­ing pro­gram in the his­to­ry of the Euro­pean Union. With a bud­get of €95.5 bil­lion for the years 2021 – 2027, it offers exten­sive fund­ing oppor­tu­ni­ties for projects with high devel­op­ment and imple­men­ta­tion potential.

Who Can Ben­e­fit from Our Support?

The ICP MTH ser­vices are avail­able to: research insti­tutes, uni­ver­si­ties, pub­lic admin­is­tra­tion enti­ties, large enter­pris­es, SMEs, start-ups, asso­ci­a­tions, foun­da­tions, and inter­na­tion­al orga­ni­za­tions inter­est­ed in imple­ment­ing research and inno­va­tion projects in the field of health and med­ical technologies.

The scope of our activ­i­ties includes:

  • assist­ing in iden­ti­fy­ing suit­able inter­na­tion­al part­ners for project collaboration,
  • rep­re­sent­ing Pol­ish insti­tu­tions at match­mak­ing and bro­ker­age events,
  • orga­niz­ing the­mat­ic train­ings and workshops,
  • pro­vid­ing indi­vid­ual con­sul­ta­tions dur­ing the prepa­ra­tion of project proposals.

How Can We Help?

The Nation­al Con­tact Point for Med­ical Tech­nolo­gies and Health focus­es on key research and devel­op­ment areas such as coör­di­nat­ed health­care and telemed­i­cine, bioin­for­mat­ics and dig­i­tal tools sup­port­ing ther­a­peu­tic process­es, mod­ern and per­son­al­ized diag­nos­tics, bio­med­ical engi­neer­ing and pro­tein ther­a­pies, as well as the devel­op­ment of inno­v­a­tive mate­ri­als for med­ical appli­ca­tions and advanced tech­nolo­gies for the man­u­fac­tur­ing of med­i­c­i­nal prod­ucts, includ­ing advanced ther­a­py med­i­c­i­nal prod­ucts (ATMPs).

The Hori­zon Europe Pro­gram is the largest research and inno­va­tion fund­ing pro­gram in the his­to­ry of the Euro­pean Union. With a bud­get of €95.5 bil­lion for the years 2021 – 2027, it offers exten­sive fund­ing oppor­tu­ni­ties for projects with high devel­op­ment and imple­men­ta­tion potential.

Who Can Ben­e­fit from Our Support?

The ICP MTH ser­vices are avail­able to: research insti­tutes, uni­ver­si­ties, pub­lic admin­is­tra­tion enti­ties, large enter­pris­es, SMEs, start-ups, asso­ci­a­tions, foun­da­tions, and inter­na­tion­al orga­ni­za­tions inter­est­ed in imple­ment­ing research and inno­va­tion projects in the field of health and med­ical technologies.

Read the Abstracts from Our Invit­ed Speakers

Can­cer Biology

Can­cer Neuroscience

Can­cer Therapy

PORT for Busi­ness — Com­pa­ny Session